open access

Vol 7, No 3 (2005)
Published online: 2005-11-07
Get Citation

Differential diagnosis of gingival hyperplasia based on IFNgamma-stimulated gene expression using RT-PCR

Iwona Niedzielska, Daniel Sypniewski, Daria Wziątek-Kuczmik
Chirurgia Polska 2005;7(3):174-179.

open access

Vol 7, No 3 (2005)
Published online: 2005-11-07

Abstract

Background: Epulus is a benign gingival tumour of unknown etiopathgenesis. Classification is inconsistent, and standard management strategies are lacking. Epuli are generally believed to be inflammatory rather than neoplastic lesions. The literature does not present any molecular analysis of the tumours’ characteristics. Aim of study: The purpose of the present study was to compare benign (epulus) and malignant (cancer) gingival hyperplasias with regard to the activity of the genes of apoptosis, proliferation, and inflammation using RT-PCR.
Material and methods: The investigation involved 70 patients with epuli and 15 patients with gingival squamous cell carcinoma. Each subject had specimens collected from the tumour, tissue margin (incision line), and healthy tissue. Molecular investigations by RT-PCR were used to evaluate expression levels of the genes of apoptosis (BCL-2, BAX, BCL-2/BAX), proliferation (H3 histone), and inflammatory processes (IFNγ, IFNγR1, IFNγR2, IFNγR1/IFNγR2).
Results: Correlations were discovered between apoptosis and proliferation gene expression in giant cell puli and high-differentiated gingival squamous cell carcinoma.
Conclusions: In RT-PCR molecular analysis, giant cell epulus shows characteristics of a neoplastic lesion while other epulus types seem to be inflammatory tumours.

Abstract

Background: Epulus is a benign gingival tumour of unknown etiopathgenesis. Classification is inconsistent, and standard management strategies are lacking. Epuli are generally believed to be inflammatory rather than neoplastic lesions. The literature does not present any molecular analysis of the tumours’ characteristics. Aim of study: The purpose of the present study was to compare benign (epulus) and malignant (cancer) gingival hyperplasias with regard to the activity of the genes of apoptosis, proliferation, and inflammation using RT-PCR.
Material and methods: The investigation involved 70 patients with epuli and 15 patients with gingival squamous cell carcinoma. Each subject had specimens collected from the tumour, tissue margin (incision line), and healthy tissue. Molecular investigations by RT-PCR were used to evaluate expression levels of the genes of apoptosis (BCL-2, BAX, BCL-2/BAX), proliferation (H3 histone), and inflammatory processes (IFNγ, IFNγR1, IFNγR2, IFNγR1/IFNγR2).
Results: Correlations were discovered between apoptosis and proliferation gene expression in giant cell puli and high-differentiated gingival squamous cell carcinoma.
Conclusions: In RT-PCR molecular analysis, giant cell epulus shows characteristics of a neoplastic lesion while other epulus types seem to be inflammatory tumours.
Get Citation

Keywords

epulus; gingival squamous cell carcinoma; RT-PCR; IFNγ; apoptosis; proliferation

About this article
Title

Differential diagnosis of gingival hyperplasia based on IFNgamma-stimulated gene expression using RT-PCR

Journal

Chirurgia Polska (Polish Surgery)

Issue

Vol 7, No 3 (2005)

Pages

174-179

Published online

2005-11-07

Bibliographic record

Chirurgia Polska 2005;7(3):174-179.

Keywords

epulus
gingival squamous cell carcinoma
RT-PCR
IFNγ
apoptosis
proliferation

Authors

Iwona Niedzielska
Daniel Sypniewski
Daria Wziątek-Kuczmik

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaBy "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl